Venki Sundaram1, Caroline Wilde2, Jonathan Aboshiha1, Jill Cowing2, Colin Han3, Christopher S Langlo4, Ravinder Chana1, Alice E Davidson1, Panagiotis I Sergouniotis2, James W Bainbridge1, Robin R Ali2, Alfredo Dubra5, Gary Rubin2, Andrew R Webster1, Anthony T Moore1, Marko Nardini2, Joseph Carroll6, Michel Michaelides7. 1. UCL Institute of Ophthalmology, University College London, London, UK; Moorfields Eye Hospital, London, UK. 2. UCL Institute of Ophthalmology, University College London, London, UK. 3. Summer Program for Undergraduate Research, Medical College of Wisconsin, Milwaukee, Wisconsin. 4. Department of Cell Biology, Neurobiology & Anatomy, Medical College of Wisconsin, Milwaukee, Wisconsin. 5. Department of Ophthalmology, Medical College of Wisconsin, Milwaukee, Wisconsin; Department of Biophysics, Medical College of Wisconsin, Milwaukee, Wisconsin. 6. Department of Cell Biology, Neurobiology & Anatomy, Medical College of Wisconsin, Milwaukee, Wisconsin; Department of Ophthalmology, Medical College of Wisconsin, Milwaukee, Wisconsin; Department of Biophysics, Medical College of Wisconsin, Milwaukee, Wisconsin. 7. UCL Institute of Ophthalmology, University College London, London, UK; Moorfields Eye Hospital, London, UK. Electronic address: michel.michaelides@ucl.ac.uk.
Abstract
PURPOSE: To characterize retinal structure and function in achromatopsia (ACHM) in preparation for clinical trials of gene therapy. DESIGN: Cross-sectional study. PARTICIPANTS: Forty subjects with ACHM. METHODS: All subjects underwent spectral domain optical coherence tomography (SD-OCT), microperimetry, and molecular genetic testing. Foveal structure on SD-OCT was graded into 5 distinct categories: (1) continuous inner segment ellipsoid (ISe), (2) ISe disruption, (3) ISe absence, (4) presence of a hyporeflective zone (HRZ), and (5) outer retinal atrophy including retinal pigment epithelial loss. Foveal and outer nuclear layer (ONL) thickness was measured and presence of hypoplasia determined. MAIN OUTCOME MEASURES: Photoreceptor appearance on SD-OCT imaging, foveal and ONL thickness, presence of foveal hypoplasia, retinal sensitivity and fixation stability, and association of these parameters with age and genotype. RESULTS: Forty subjects with a mean age of 24.9 years (range, 6-52 years) were included. Disease-causing variants were found in CNGA3 (n = 18), CNGB3 (n = 15), GNAT2 (n = 4), and PDE6C (n = 1). No variants were found in 2 individuals. In all, 22.5% of subjects had a continuous ISe layer at the fovea, 27.5% had ISe disruption, 20% had an absent ISe layer, 22.5% had an HRZ, and 7.5% had outer retinal atrophy. No significant differences in age (P = 0.77), mean retinal sensitivity (P = 0.21), or fixation stability (P = 0.34) across the 5 SD-OCT categories were evident. No correlation was found between age and foveal thickness (P = 0.84) or between age and foveal ONL thickness (P = 0.12). CONCLUSIONS: The lack of a clear association of disruption of retinal structure or function in ACHM with age suggests that the window of opportunity for intervention by gene therapy is wider in some individuals than previously indicated. Therefore, the potential benefit for a given subject is likely to be better predicted by specific measurement of photoreceptor structure rather than simply by age. The ability to directly assess cone photoreceptor preservation with SD-OCT and/or adaptive optics imaging is likely to prove invaluable in selecting subjects for future trials and measuring the trials' impact.
PURPOSE: To characterize retinal structure and function in achromatopsia (ACHM) in preparation for clinical trials of gene therapy. DESIGN: Cross-sectional study. PARTICIPANTS: Forty subjects with ACHM. METHODS: All subjects underwent spectral domain optical coherence tomography (SD-OCT), microperimetry, and molecular genetic testing. Foveal structure on SD-OCT was graded into 5 distinct categories: (1) continuous inner segment ellipsoid (ISe), (2) ISe disruption, (3) ISe absence, (4) presence of a hyporeflective zone (HRZ), and (5) outer retinal atrophy including retinal pigment epithelial loss. Foveal and outer nuclear layer (ONL) thickness was measured and presence of hypoplasia determined. MAIN OUTCOME MEASURES: Photoreceptor appearance on SD-OCT imaging, foveal and ONL thickness, presence of foveal hypoplasia, retinal sensitivity and fixation stability, and association of these parameters with age and genotype. RESULTS: Forty subjects with a mean age of 24.9 years (range, 6-52 years) were included. Disease-causing variants were found in CNGA3 (n = 18), CNGB3 (n = 15), GNAT2 (n = 4), and PDE6C (n = 1). No variants were found in 2 individuals. In all, 22.5% of subjects had a continuous ISe layer at the fovea, 27.5% had ISe disruption, 20% had an absent ISe layer, 22.5% had an HRZ, and 7.5% had outer retinal atrophy. No significant differences in age (P = 0.77), mean retinal sensitivity (P = 0.21), or fixation stability (P = 0.34) across the 5 SD-OCT categories were evident. No correlation was found between age and foveal thickness (P = 0.84) or between age and foveal ONL thickness (P = 0.12). CONCLUSIONS: The lack of a clear association of disruption of retinal structure or function in ACHM with age suggests that the window of opportunity for intervention by gene therapy is wider in some individuals than previously indicated. Therefore, the potential benefit for a given subject is likely to be better predicted by specific measurement of photoreceptor structure rather than simply by age. The ability to directly assess cone photoreceptor preservation with SD-OCT and/or adaptive optics imaging is likely to prove invaluable in selecting subjects for future trials and measuring the trials' impact.
Authors: S Johnson; M Michaelides; I A Aligianis; J R Ainsworth; J D Mollon; E R Maher; A T Moore; D M Hunt Journal: J Med Genet Date: 2004-02 Impact factor: 6.318
Authors: Mohamed A Genead; Gerald A Fishman; Jungtae Rha; Adam M Dubis; Daniela Maria O Bonci; Alfredo Dubra; Edwin M Stone; Maureen Neitz; Joseph Carroll Journal: Invest Ophthalmol Vis Sci Date: 2011-09-21 Impact factor: 4.799
Authors: I A Aligianis; T Forshew; S Johnson; M Michaelides; C A Johnson; R C Trembath; D M Hunt; A T Moore; E R Maher Journal: J Med Genet Date: 2002-09 Impact factor: 6.318
Authors: Alberta A H J Thiadens; Anneke I den Hollander; Susanne Roosing; Sander B Nabuurs; Renate C Zekveld-Vroon; Rob W J Collin; Elfride De Baere; Robert K Koenekoop; Mary J van Schooneveld; Tim M Strom; Janneke J C van Lith-Verhoeven; Andrew J Lotery; Norka van Moll-Ramirez; Bart P Leroy; L Ingeborgh van den Born; Carel B Hoyng; Frans P M Cremers; Caroline C W Klaver Journal: Am J Hum Genet Date: 2009-07-16 Impact factor: 11.025
Authors: Y Huang; A V Cideciyan; G I Papastergiou; E Banin; S L Semple-Rowland; A H Milam; S G Jacobson Journal: Invest Ophthalmol Vis Sci Date: 1998-11 Impact factor: 4.799
Authors: S Kohl; T Marx; I Giddings; H Jägle; S G Jacobson; E Apfelstedt-Sylla; E Zrenner; L T Sharpe; B Wissinger Journal: Nat Genet Date: 1998-07 Impact factor: 38.330
Authors: Livia S Carvalho; Jianhua Xu; Rachael A Pearson; Alexander J Smith; James W Bainbridge; Lynsie M Morris; Steven J Fliesler; Xi-Qin Ding; Robin R Ali Journal: Hum Mol Genet Date: 2011-05-15 Impact factor: 6.150
Authors: Shu Feng; Michael J Gale; Jonathan D Fay; Ambar Faridi; Hope E Titus; Anupam K Garg; Keith V Michaels; Laura R Erker; Dawn Peters; Travis B Smith; Mark E Pennesi Journal: Invest Ophthalmol Vis Sci Date: 2015-09 Impact factor: 4.799
Authors: Melissa A Wilk; Brandon M Wilk; Christopher S Langlo; Robert F Cooper; Joseph Carroll Journal: Vision Res Date: 2016-12-02 Impact factor: 1.886
Authors: Adam M Dubis; Robert F Cooper; Jonathan Aboshiha; Christopher S Langlo; Venki Sundaram; Benjamin Liu; Frederick Collison; Gerald A Fishman; Anthony T Moore; Andrew R Webster; Alfredo Dubra; Joseph Carroll; Michel Michaelides Journal: Invest Ophthalmol Vis Sci Date: 2014-10-02 Impact factor: 4.799
Authors: Katie M Litts; Michalis Georgiou; Christopher S Langlo; Emily J Patterson; Rebecca R Mastey; Angelos Kalitzeos; Rachel E Linderman; Byron L Lam; Gerald A Fishman; Mark E Pennesi; Christine N Kay; William W Hauswirth; Michel Michaelides; Joseph Carroll Journal: Curr Eye Res Date: 2020-03-13 Impact factor: 2.424
Authors: Drew Scoles; Yusufu N Sulai; Christopher S Langlo; Gerald A Fishman; Christine A Curcio; Joseph Carroll; Alfredo Dubra Journal: Invest Ophthalmol Vis Sci Date: 2014-06-06 Impact factor: 4.799
Authors: Susanne Kohl; Ditta Zobor; Wei-Chieh Chiang; Nicole Weisschuh; Jennifer Staller; Irene Gonzalez Menendez; Stanley Chang; Susanne C Beck; Marina Garcia Garrido; Vithiyanjali Sothilingam; Mathias W Seeliger; Franco Stanzial; Francesco Benedicenti; Francesca Inzana; Elise Héon; Ajoy Vincent; Jill Beis; Tim M Strom; Günther Rudolph; Susanne Roosing; Anneke I den Hollander; Frans P M Cremers; Irma Lopez; Huanan Ren; Anthony T Moore; Andrew R Webster; Michel Michaelides; Robert K Koenekoop; Eberhart Zrenner; Randal J Kaufman; Stephen H Tsang; Bernd Wissinger; Jonathan H Lin Journal: Nat Genet Date: 2015-06-01 Impact factor: 38.330